A BTK inhibitor combined with standard R-CHOP produced rapid, PET-defined complete remission in high-risk DLBCL-type Richter syndrome with TP53 deletion. Delaying ibrutinib until cycle 2 was used as a ...
Dal research teams receive more than $7.3M in Canada Foundation for Innovation support to expand labs and tools driving breakthroughs in water resilience, ocean science, marine tracking, and digital s ...
How do blood vessels stay strong, flexible, and responsive to the body's changing need for oxygen and nutrients? The answer lies not only in biology—but also in physics. Researchers at Åbo Akademi ...
Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...
As non-animal models move mainstream, the focus is shifting toward reproducibility and data integrity. By using specialized ...
The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results